drugset / Trial / NCT02172248
Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective was to investigate a possible drug-drug interaction between BI 10773 and metformin when co-administered as multiple oral doses. Therefore, the relative bioavailabilities of BI 10773 and metformin were determined when both drugs were given in combination compared with BI 10773 or metformin given alone.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 50 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.